Patient-Specific Dosimetric Validation of Pelvic IMRT and VMAT Plans Using a Custom-designed Female Pelvic Phantom and Arc-CHECK QA System

Document Type : Original Paper

Authors

1 Department of Physics, School of Chemical Engineering and Physical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India

2 Department of Radiation Oncology, Max Superspeciality Hospital, Saket, Delhi, India

3 Department of Radiation Oncology, N M Virani Wockhardt Hospital, Rajkot, Gujrat, India

4 Department of Radiation Oncology, Sir Sayajirao General Hospital, Vadodara, Gujrat

5 Dept. of Physics, School of Chemical Engineering and Physical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India

10.22038/ijmp.2026.91845.2648

Abstract

Introduction: To ensure the accuracy of advanced radiotherapy techniques in the therapy of female pelvic malignancies using radiotherapy, comprehensive quality assurance protocols and patient-specific dosimetry was performed using a custom-designed female pelvic (CDFP) phantom and Arc-CHECK.
Material and Methods: Volumetric modulated arc therapy (VMAT) and Intensity modulated radiation therapy (IMRT) plans originally developed for patients with cervical cancer were transferred to the CDFP phantom and Arc-CHECK. The doses for patient-specific quality assurance (PSQA) of advanced techniques were calculated using different algorithms in treatment planning system (TPS). To acquire dose measurements, a 0.600 cc ion chamber, Sun Nuclear 125c (SNC125c) and a pinpoint 0.015 cc chamber were employed. The percentage deviation between the computed and administered dose was calculated.
 
Results: Percentage discrepancies between planned and administered doses were analyzed. The maximum percentage deviation, mean ± standard deviation(SD) differences for 0.6 cc ion chamber and a pin-point 0.015 cc chamber were found to be -3.6%, -0.89% ± 1.59  and 3.51%, 1.10% ± 1.31  for the IMRT treatment technique and -3.32%, -0.84% ± 1.53 and 3.6%, 1.25% ± 1.34 for the VMAT treatment technique using AAA algorithms using 6MV beam for CDFP phantom respectively. The maximum of percentage deviation, mean ± SD differences for 0.6 cc ion chamber and a SNC125c chamber were found to be -3.40%, -0.273% ± 2.161 and 3.107%, -0.028% ± 2.046  for CDFP phantom and -2.72%, -0.35% ± 1.41 and 2.74%, 0.197% ± 1.50 for Arc-CHECK using VMAT treatment technique using 6MV beam and Monte Carlo algorithm respectively.
Conclusion: The inherent properties of anthropomorphic phantoms like the CDFP, such an anatomical fidelity and tissue equivalence, make them extremely useful in the quality assurance radiotherapy-programs. Their application increases the accuracy of dosimetric validation and therefore, these phantoms are applicable in the use of high-accuracy treatment modalities such as IMRT and VMAT

Keywords

Main Subjects

References

  1. Singh B, Singh G, Oinam AS, Kumar V, Vashistha R, Sidhu MS, et al. Radiobiological modeling of radiation-induced acute rectal mucositis: A single-institutional study of cervical carcinoma. J Cancer Res Ther. 2023;19(Suppl 1):S328--S34.
  2. Shirzadfar H, Khanahmadi M. Current approaches and novel treatment methods for cancer and radiotherapy. Int J Biosens and Bioelectron. 2018;4(5):224–
  3. Yadav N, Singh M, Mishra SP. Tissue-equivalent materials used to develop phantoms in radiation dosimetry: A review. Materials Today: Proceedings. 2021 Jan 1;47:7170-3.
  4. Tillery H, Moore M, Gallagher KJ, Taddei PJ, Leuro E, Argento D, et al. Personalized 3D-printed anthropomorphic whole-body phantom irradiated by protons, photons, and neutrons. Biomed Phys and Eng Express. 2022;8(2):27004.
  5. Cunningham JM, Barberi EA, Miller J, Kim JP, Glide-Hurst CK. Development and evaluation of a novel MR-compatible pelvic end-to-end phantom. J Appl Clin Med Phys. 2019;20(1):265–
  6. Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys. 2008;35(1):310–
  7. Gregoire V, MacKie TR. Dose prescription, reporting and recording in intensity-modulated radiation therapy: A digest of the ICRU report 83. Imaging Med. 2011;3(3):367–
  8. Olch A, Moran J, Pawlicki T, Li H, Low DA. Tolerance limits and methodologies for IMRT measurement-based veri fi cation QA : Recommendations of AAPM Task Group No . 218. 2018;45(218):53–
  9. Followill DS, Evans R, Cherry C, Molineu A, Fisher G, Hanson WF, et al. Design , development , and implementation of the Radiological Physics Centers pelvis and thorax anthropomorphic quality assurance phantoms. 2007;2070–
  10. Rodrigues F, Nolasco A, Meira Belo LC, Silva C, Fonseca T. Assessment of dose heterogeneity in TBI using the thorax of the anthropomorphic Alderson-Rando phantom and TLDs in two different setups. Brazilian J Radiat Sci. 2023 Jun 19;11(1A (Suppl.)):01–
  11. Yadav N, Singh M, MISHRA SP, ANSARI MS, Mishra A. Design and development of an anthropomorphic heterogeneous female pelvic (AHFP) phantom for dosimetric verification of advance radiotherapy. Iran J Med Phys [Internet]. 2023;
  12. Létourneau D, Publicover J, Kozelka J, Moseley DJ, Jaffray DA. Novel dosimetric phantom for quality assurance of volumetric modulated arc therapy. Med Phys. 2009;36(5):1813–
  13. Gurjar OP, Mishra SP. A comparative study on patient specific absolute dosimetry using slab phantom, acrylic body phantom and goat head phantom. Int J Cancer Ther Oncol. 2015;3:3212.
  14. Yadav N, Singh M, Mishra SP, Ansari S. Development of an Anthropomorphic Heterogeneous Female Pelvic Phantom and Its Comparison with a Homogeneous Phantom in Advance Radiation Therapy: Dosimetry Analysis. Med Sci. 2023 Sep 11;11(3):59.
  15. Cook H, Lambert J, Thomas R, Palmans H, Hussein M, Clark CH, et al. Development of a heterogeneous phantom to measure range in clinical proton therapy beams. Phys Medica [Internet]. 2022;93(June 2021):59–
  16. Mather SJ, Mansi L. IAEA Technical Report Series. Eur J Nucl Med Mol Imaging. 2008;35(5):1030–
  17. Andreo P, Aspradakis M, Burns D, Büermann L, Carrara M, Christaki K, et al. TECHNICAL REPORTS SERIES No. 398 (Rev. 1), Absorbed dose determination in external beam radiotherapy. 2024;398(398):1–
  18. Dong L, Antolak J, Salehpour M, Forster K, O Neill L, Kendall R, et al. Patient-specific point dose measurement for IMRT monitor unit verification. Int J Radiat Oncol Biol Phys. 2003;56(3):867–
  19. Low DA, Moran JM, Dempsey JF, Dong L, Oldham M. Dosimetry tools and techniques for IMRT. Med Phys. 2011;38(3):1313–
  20. Miften M, Olch A, Mihailidis D, Moran J, Pawlicki T, Molineu A, et al. Tolerance limits and methodologies for IMRT measurement-based verification QA: Recommendations of AAPM Task Group No. 218. Med Phys. 2018 Apr 1;45(4):e53–
  21. Gurjar OP, Mishra SP, Bhandari V, Pathak P, Patel P, Shrivastav G. Radiation dose verification using real tissue phantom in modern radiotherapy techniques. J Med Physics. 2014;39(1):44.
  22. Kry SF, Alvarez P, Molineu A, Amador C, Galvin J, Followill DS. Algorithms used in heterogeneous dose calculations show systematic differences as measured with the radiological physics center’s anthropomorphic thorax phantom used for RTOG credentialing. Int J Radiat Oncol Biol Phys [Internet]. 2013;85(1):e95–
  23. Dubey S, Bagdare P, Ghosh S. Dosimetric evaluation of analytic anisotropic algorithm and Acuros XB algorithm using in-house developed heterogeneous thorax phantom and homogeneous slab phantom for stereotactic body radiation therapy technique. Radiat Prot Environ. 2021;44(2):110–
  24. Gangwar VK, Agarwal A, Gurjar OP, Kumar L, Mishra VK, Mishra SP. Suitability Assessment of an Indigenous Heterogeneous Thoracic Phantom for Patient-Specific Quality Assurance in Radiotherapy. Iran J Med Phys. 2022 Mar 1;19(2):85–
  25. Kishore V, Kumar L, Bhushan M, Yadav G. A study for the development of a low density heterogeneous phantom for dose verification in high energy photon beam. Radiat Phys Chem [Internet]. 2020;170(June 2019):108638.
  26. Singh S, Raina P, Gurjar OP. Dosimetric study of an indigenous and heterogeneous pelvic phantom for radiotherapy quality assurance. Iran J Med Phys. 2020;17(2):120–
  27. Singh S, Raina P, Gurjar OP. Point dose measurement for verification of treatment planning system using an indigenous heterogeneous pelvis phantom for clarkson, convolution, superposition, and fast superposition algorithms. J Biomed Phys Eng. 2019;9(6):613–
  28. Kumar L, Kishore V, Bhushan M, Kumar P, Kumar G. Design and fabrication of a thoracic phantom for radiation dose verification in mega-voltage X-ray beam. In: Materials Today: Proceedings. Elsevier Ltd. 2020. 3050–
  29. Yadav N, Singh M, Mishra SP, Ansari S. Development of Anthropomorphic Heterogeneous Pelvic Phantom and Its Comparison with Homogeneous Phantom in Advance Radiation Therapy: Dosimetry Analysis. 2023.
Iranian Journal of Medical Physics
Volume 22, Issue 6 - Serial Number 6
November and December 2025
Pages 395-404

Files

History

  • Receive Date: 13 November 2025
  • Revise Date: 29 December 2025
  • Accept Date: 05 February 2026

Share

How to cite

Statistics